๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

26 recruiting trials

for Osteosarcoma Recurrent

Study in Children and Adolescents of 177Lu-DOTATATE (Lutatheraยฎ) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site๐Ÿ“ Boadilla del Monte Fundaciรณn de investigaciรณn HM ยท Tests: Olaparib; 177Lu-DOTATATE Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial NCT07227571Phase 11 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: FH FOLR1 ST CAR T-cells, Leukapheresis, Fludarabine, Cyclophosphamide, Echocardiography Test 68Ga-B7-H3 Nanobody ImmunoPET in Osteosarcoma NCT07774533EARLY Phase 11 site๐Ÿ“ Beijing Peking University First Hospital ยท Tests: 68Ga-B7-H3 Nanobody PET/CT NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma NCT07211737Phase 11 site๐Ÿ“ Houston Baylor College of Medicine ยท Tests: i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells, i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells, i15.NKG2D.zeta NK celโ€ฆ Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas NCT06156410Phase 14 sites๐Ÿ“ San Francisco๐Ÿ“ Aurora๐Ÿ“ Philadelphia Children's Hospital of Philadelphia ยท Tests: Cabozantinib Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) NCT07297979Phase 111 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Baltimore Amgen ยท Tests: Xaluritamig Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance NCT07636148n/a3 sites๐Ÿ“ Lyon๐Ÿ“ Crรฉteil๐Ÿ“ Leiden Mark C Burgmans, MD PhD Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma NCT05588648Phase 1, Phase 27 sites๐Ÿ“ Cleveland๐Ÿ“ Gyeonggi-do๐Ÿ“ Gyeonggi-do MedPacto, Inc. ยท Tests: Vactosertib Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma NCT06340204Phase 13 sites๐Ÿ“ Jina๐Ÿ“ Beijin๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Irinotecan Hydrochloride Liposome Injection Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma NCT06827717Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: irinotecan liposome (II) + temozolomide + fluzoparib DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma NCT06892678Phase 1, Phase 21 site๐Ÿ“ The Bronx Montefiore Medical Center ยท Tests: DFMO Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma NCT07479732Phase 1, Phase 21 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Liposomal Irinotecan, Apatinib in arm1 Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial NCT06114225Phase 21 site๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: metastasectomy and pre-operative immunotherapy (gemcitabine and penpulimab ) and stereotactic body radiotherapy A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors NCT05135975Phase 26 sites๐Ÿ“ Birmingham๐Ÿ“ Aurora๐Ÿ“ Washington D.C. Nationwide Children's Hospital ยท Tests: Cabozantinib Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma NCT07144254Phase 12 sites๐Ÿ“ Atlanta๐Ÿ“ Houston Emory University ยท Tests: Tegavivint, Gemcitabine Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma NCT06492954Phase 11 site๐Ÿ“ Atlanta Emory University ยท Tests: Surgical Resection, Stereotactic Body Radiation Therapy (SBRT), Atezolizumab HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma NCT04995003Phase 11 site๐Ÿ“ Houston Baylor College of Medicine ยท Tests: T cells or CAR T cells, Pembrolizumab Injectable Product, Nivolumab Injectable Product Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma NCT05400603Phase 11 site๐Ÿ“ Atlanta Emory University ยท Tests: Ex Vivo Expanded Allogeneic ฮณฮด T Cells in Combination with Dinutuximab, Temozolomide, Irinotecan and Zoledronate Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma NCT04901702Phase 1, Phase 210 sites๐Ÿ“ Palo Alto๐Ÿ“ Aurora๐Ÿ“ Washington D.C. St. Jude Children's Research Hospital ยท Tests: Onivyde, Talazoparib, Temozolomide Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study NCT05019703Phase 22 sites๐Ÿ“ Boston๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Atezolizumab, Cabozantinib Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors NCT04851119Phase 1, Phase 221 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Orange Children's Oncology Group ยท Tests: Biospecimen Collection, Dual X-ray Absorptiometry, Tegavivint, X-Ray Imaging Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors NCT02013336Phase 15 sites๐Ÿ“ Cincinnati๐Ÿ“ Oklahoma City๐Ÿ“ Dallas South Plains Oncology Consortium ยท Tests: MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide B7-H3 NIR Imaging for Osteosarcoma Surgery NCT06778603Phase 1, Phase 21 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: a targeted probe B7H3-IRDye800CW Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor NCT04616560Phase 232 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Orange National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Computed Tomography, Echocardiography Test, Magnetic Resonance Imaging, Multigated Acquisition โ€ฆ Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment NCT01790152n/a79 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Tucson Children's Oncology Group ยท Tests: Assessment of Therapy Complications, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administrโ€ฆ Iscadorยฎ P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma NCT05726383Phase 22 sites๐Ÿ“ Hackensack๐Ÿ“ Houston Hackensack Meridian Health ยท Tests: Iscador*P
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy